MedixMedix Inc.331A東証スタンダードサービス業FY ending Mar 2026, consolidated, J-GAAP

Medix FY ending Mar 2026 results

Medix brought in ¥4.26B in revenue.

Out of every ¥100 of sales, about ¥16 is left as operating profit.

Revenue changed +2.3% from the prior year, operating profit -17.8%.

What changed from last year

FY ending Mar 2025 → FY ending Mar 2026

Revenue
+2.3%¥4.16B → ¥4.26B
Gross profit
-0.7%¥3.73B → ¥3.7B
Operating income
-17.8%¥802.6M → ¥659.4M
Operating cash flow
-49.4%¥499.9M → ¥252.7M
Free cash flow
-55.6%¥482.7M → ¥214.2M

Where the money goes

FY ending Mar 2025 → FY ending Mar 2026

Where ¥100 of sales goes

For every ¥100 Medix sells, how much goes where, and how much is kept.

FY ending Mar 2026
Cost of sales
¥13
SG&A
¥71
Operating profit
¥16
Net profit kept
¥10

Annual margin trends

Gross margin87.0%
FY ending Mar 2024: 89.4%89.4%FY ending Mar 2025: 89.6%89.6%FY ending Mar 2026: 87.0%87.0%FY24FY25FY26
Operating margin15.5%
FY ending Mar 2024: 19.2%19.2%FY ending Mar 2025: 19.3%19.3%FY ending Mar 2026: 15.5%15.5%FY24FY25FY26
Net margin10.3%
FY ending Mar 2024: 11.7%11.7%FY ending Mar 2025: 19.3%19.3%FY ending Mar 2026: 10.3%10.3%FY24FY25FY26

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (2)
  • EDINET (FSA Japan)

    有価証券報告書-第43期(2025/04/01-2026/03/31)

    ID S100YHLO2026-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第42期(2024/04/01-2025/03/31)

    ID S100W5702025-06-26Open

Extracted from XBRL: 50 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.